The latest initiative comes more than three decades after the colorant was barred from cosmetics and non-oral medications due to potentially causing cancer. “On January 15, 2025, the FDA issued ...
The FDA has approved a new treatment for patients with a common form of breast cancer that has spread to other parts of the ...
News Medical on MSN1d
New research shines light on position-specific hallmarks of cancerA team led by the Cancer Immunogenomics group at the Josep Carreras Leukaemia Research Institute, the Computational Biology group at the Barcelona Supercomputing Center and the Germans Trias i Pujol ...
The Food and Drug Administration has removed webpages about diversity and inclusion in clinical trials for cancer drugs. The page for Project Equity, a 2021 initiative launched by the FDA's ...
The clearance of Datroway comes months after the companies narrowed approval plans in lung cancer and opens up a market ...
The approval emphasizes the importance of HER2 status testing in metastatic breast cancer to identify eligible patients for Enhertu treatment. The antibody drug conjugate was approved for patients ...
The latest initiative comes more than three decades after the colorant was barred from cosmetics and non-oral medications due to potentially causing cancer. “On January 15, 2025, the FDA issued an ...
A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback